Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 September 2007, Vol. 110, No. 5, pp. 1448-1457.
Prepublished online as a Blood First Edition Paper on April 24, 2007; DOI 10.1182/blood-2006-12-060814.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2006-12-060814v1
110/5/1448    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, F.
Right arrow Articles by Thrasher, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, F.
Right arrow Articles by Thrasher, A. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted December 5, 2006
Accepted April 20, 2007

Lentiviral vectors containing an enhancer-less ubiquitously-acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in haematopoietic cells

Fang Zhang, Susannah I Thornhill, Steven J Howe, Meera Ulaganathan, Axel Schambach, Joanna Sinclair, Christine Kinnon, H Bobby Gaspar, Michael Antoniou, and Adrian J. Thrasher*

Molecular Immunology Unit, Centre for Immunodeficiency, Institute of Child Health, University College London, London, United Kingdom
Department of Experimental Hematology, Hannover Medical School, Hannover, Germany
Department of Clinical Immunology, Great Ormond Street Hospital NHS Trust, London, United Kingdom
Department of Medical and Molecular Genetics, Nuclear Biology Group, Kings College London School of Medicine, London, United Kingdom

* Corresponding author; email: a.thrasher{at}ich.ucl.ac.uk.

Ubiquitously-acting chromatin opening elements (UCOEs) consist of methylation-free CpG islands encompassing dual, divergently transcribed promoters of housekeeping genes which have been shown to confer resistance to transcriptional silencing and to produce consistent and stable transgene expression in tissue culture systems. To develop improved strategies for haematopoietic cell gene therapy we have assessed the potential of the novel human HNRPA2B1-CBX3 UCOE (A2UCOE) within the context of a SIN lentiviral vector. Unlike viral promoters, the enhancer-less A2UCOE gave rise to populations of cells that expressed a reporter transgene at a highly reproducible level. The efficiency of expression per vector genome was also markedly increased in vivo compared to vectors incorporating either SFFV or CMV promoters, suggesting a relative resistance to silencing. Furthermore, an A2UCOE-IL2RG vector fully restored the IL-2 signalling pathway within IL2RG deficient human cells in vitro and successfully rescued the SCID-X1 phenotype in a mouse model of this disease. These data indicate that the A2UCOE displays highly reliable transcriptional activity within a lentiviral vector, largely overcoming insertion site position effects and giving rise to therapeutically relevant levels of gene expression. These properties are achieved in the absence of classical enhancer activity and therefore may confer a high safety profile.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
R. E. Throm, A. A. Ouma, S. Zhou, A. Chandrasekaran, T. Lockey, M. Greene, S. S. De Ravin, M. Moayeri, H. L. Malech, B. P. Sorrentino, et al.
Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection
Blood, May 21, 2009; 113(21): 5104 - 5110.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Bokhoven, S. L. Stephen, S. Knight, E. F. Gevers, I. C. Robinson, Y. Takeuchi, and M. K. Collins
Insertional Gene Activation by Lentiviral and Gammaretroviral Vectors
J. Virol., January 1, 2009; 83(1): 283 - 294.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Si, A. C. Pulliam, Y. Linka, S. Ciccone, C. Leurs, J. Yuan, O. Eckermann, S. Fruehauf, S. Mooney, H. Hanenberg, et al.
Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells
Blood, December 1, 2008; 112(12): 4458 - 4465.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Senigl, J. Plachy, and J. Hejnar
The Core Element of a CpG Island Protects Avian Sarcoma and Leukosis Virus-Derived Vectors from Transcriptional Silencing
J. Virol., August 15, 2008; 82(16): 7818 - 7827.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020